(Total Views: 444)
Posted On: 08/07/2019 4:04:32 PM
Post# of 156901
Just noticed this on Gilead from my email. Trying to keep being competitive with Prep
FDA advisory committee backs Gilead's Descovy for PrEP
Aug. 7, 2019 3:51 PM ET|About: Gilead Sciences, Inc. (GILD)|By: Douglas W. House, SA News Editor
An FDA advisory committee voted 16-2 recommending approval of Gilead Sciences' (GILD -0.2%) Descovy (emtricitabine and tenofovir) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in men and transgender women who have sex with men.
The FDA's action date is in October.
LINK: https://seekingalpha.com/news/3488717-fda-adv...email_link
GLTA
HCIT
FDA advisory committee backs Gilead's Descovy for PrEP
Aug. 7, 2019 3:51 PM ET|About: Gilead Sciences, Inc. (GILD)|By: Douglas W. House, SA News Editor
An FDA advisory committee voted 16-2 recommending approval of Gilead Sciences' (GILD -0.2%) Descovy (emtricitabine and tenofovir) for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in men and transgender women who have sex with men.
The FDA's action date is in October.
LINK: https://seekingalpha.com/news/3488717-fda-adv...email_link
GLTA
HCIT
(0)
(0)
